News Sentiment

AURA sentiment intelligence

Aura Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.84 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-11.6% over one week, +6.7% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Aura Minerals bounces back from recent drop with 7% advance (AUGO:NASDAQ)

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -11.6% Price reacting lower
Trend fit Trend active 6.7% over four weeks
Fair value -9.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 43
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 10
GlobeNewswire 7
TradingView 6
simplywall.st 3
Investing.com Nigeria 2
Stock Traders Daily 2
Quiver Quantitative 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 12
Analyst action 2
Regulatory and legal 1
Balance sheet 1
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53
TradingView Direct company coverage

Price to earnings forward of Aura Biosciences, Inc. – NASDAQ:AURA

This page displays the "Price to earnings forward" metric for Aura Biosciences, Inc. (NASDAQ: AURA). It appears to be a financial data point provided by TradingView, sourcing data from ICE Data Services and FactSet. The core content focuses solely on this specific financial metri

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 13:41
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Aura Biosciences, Inc. – NASDAQ:AURA

This article provides a brief mention of Aura Biosciences, Inc. (NASDAQ: AURA) and its "Price to sales forward" metric within the context of TradingView's financial data platform. It highlights that the market was closed at the time of the article and provides no specific numeric

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 09:11
Source
TradingView
Stock Titan Direct company coverage

Jeremy Bender joins Aura Biosciences (NASDAQ: AURA) board as independent director

Aura Biosciences (NASDAQ: AURA) has appointed Jeremy Bender, Ph.D., M.B.A., as a Class II independent director to its Board of Directors, expanding the board from six to seven members. Dr. Bender will also serve on the Compensation and Nominating and Corporate Governance Committe

Tone
Positive 73/100
Event
Market update
Published
08 Jul 2026 23:17
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 Aura Biosciences Inc For: 8 July By Investing.com

This article reports on a Form 4 filing for Aura Biosciences Inc. related to activity on July 8. The news, published by Investing.com, indicates routine financial disclosure for the company.

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 23:17
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Aura Biosciences (AURA) director receives RSU and 60,000 stock option grant

Aura Biosciences, Inc. director Jeremy Bender was granted equity awards consisting of 30,000 restricted stock units (RSUs) and 60,000 stock options. The RSUs and stock options will vest in three substantially equal annual installments, contingent upon his continued service. The s

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Aura Biosciences (NASDAQ: AURA) files initial Form 3 for director Jeremy Bender

Aura Biosciences (NASDAQ: AURA) has filed an initial Form 3 for its new director, Jeremy Bender. This filing establishes Bender as a reporting person with the SEC, indicating his director status but showing no initial beneficial ownership of shares or derivative positions. The Fo

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 20:09
Source
Stock Titan
GlobeNewswire Direct company coverage

Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors

Aura Biosciences has appointed Jeremy Bender, Ph.D., M.B.A., to its Board of Directors. Dr. Bender brings extensive experience in advancing innovative therapies through development and commercialization, especially in rare oncology. His appointment comes as Aura Biosciences nears

Tone
Positive 70/100
Event
Market update
Published
08 Jul 2026 11:00
Source
GlobeNewswire
富途牛牛 Direct company coverage

Aura Biosciences Insiders Made A Wise Decision By Selling US$939k Worth Of Stock

This article discusses the recent insider selling activity at Aura Biosciences, where insiders sold US$939k worth of stock. The sale occurred between US$16.52 and US$27.00 per share, with the stock currently trading at US$17.15, suggesting the insiders made a timely decision to s

Tone
Negative 28/100
Event
Market update
Published
07 Jul 2026 11:40
Source
富途牛牛
Stock Traders Daily Direct company coverage

The Technical Signals Behind (AURA) That Institutions Follow

This article analyzes Aura Biosciences Inc. (NASDAQ: AURA) using AI models to provide technical signals for institutional trading strategies. Key findings include strong near and mid-term sentiment, resistance testing, and an exceptional risk-reward short setup. The report detail

Tone
Positive 76/100
Event
Market update
Published
06 Jul 2026 11:10
Source
Stock Traders Daily
Stock Titan Direct company coverage

If You Invested $1,000 in Aura Biosciences, Inc. (AURA)

This article examines the historical performance of investing $1,000 in Aura Biosciences, Inc. (AURA) at various points in time. It details the company's focus on developing precision therapies for solid tumors, particularly its lead product candidate bel-sar for ocular oncology

Tone
Positive 66/100
Event
Market update
Published
04 Jul 2026 10:39
Source
Stock Titan
Simply Wall Street Direct company coverage

More Money In The Bank For Aura Biosciences Insiders Who Divested US$939k

Insiders at Aura Biosciences divested US$939k worth of stock over the last 12 months, with a significant portion occurring in the last quarter. While shareholders recently saw a 13% stock price increase, the consistent insider selling below the current price, coupled with low ins

Tone
Negative 36/100
Event
Earnings
Published
03 Jul 2026 11:10
Source
Simply Wall Street
Stock Titan Direct company coverage

Executive at Aura Biosciences (AURA) receives 14,858 RSUs

Conor Kilroy, an officer at Aura Biosciences, has received a grant of 14,858 restricted stock units (RSUs) as part of the company's 2021 Stock Option and Incentive Plan, at no cash cost. These RSUs will vest in two equal annual installments starting July 15, 2027, provided Kilroy

Tone
Neutral 50/100
Event
Balance sheet
Published
01 Jul 2026 20:35
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form DEF 14A AURA BIOSCIENCES For: 29 June By Investing.com

This article announces the filing of Form DEF 14A by AURA BIOSCIENCES for June 29. It briefly highlights the company's stock performance, showing a 15.01% gain, and points readers to additional financial market data and tools available on Investing.com.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 10:09
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Aura Biosciences (NASDAQ: AURA) sets vote on 500M share authorization and equity plan tweak

Aura Biosciences is holding a virtual special stockholder meeting on August 5, 2026, to vote on two key proposals. These proposals include increasing the authorized common shares from 150 million to 500 million and amending the 2021 Stock Option and Incentive Plan to include pre-

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 21:41
Source
Stock Titan
TradingView Direct company coverage

Aura Biosciences Inc Actuals & Estimates (BOATS:AURA)

This article provides an overview of Aura Biosciences, Inc. (AURA) stock, including financial actuals and analyst estimates. It highlights the company's past earnings, revenue, and stock price performance, along with forecasts for future prices and upcoming earnings dates. The ar

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 21:41
Source
TradingView
TradingView Direct company coverage

Aura Biosciences Inc Actuals & Estimates (NASDAQ:AURA)

This article provides an overview of Aura Biosciences, Inc. (NASDAQ: AURA) stock, including its current price, market capitalization, analyst forecasts, and recent financial performance. It highlights that analysts predict a maximum price of $24.00 and a minimum of $15.00 for AUR

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 23:40
Source
TradingView
TradingView Direct company coverage

AURA Forecast — Price Target — Prediction for 2027

This article provides a forecast for Aura Biosciences, Inc. (AURA) stock, including analyst price targets, past performance, and key financial metrics. It highlights that analysts have a maximum price estimate of $24.00 and a minimum of $15.00 for AURA, while the stock has shown

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 18:40
Source
TradingView
Stock Traders Daily Direct company coverage

Precision Trading with Aura Biosciences Inc. (AURA) Risk Zones

This article provides an in-depth analysis of Aura Biosciences Inc. (AURA) stock, highlighting a current mid-channel oscillation pattern and divergent sentiment readings. It outlines three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with

Tone
Positive 71/100
Event
Market update
Published
24 Jun 2026 22:10
Source
Stock Traders Daily
TradingKey Direct company coverage

Aura Biosciences Inc (AURA) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Aura Biosciences Inc. (AURA) focusing on its dividend and stock split history. It indicates that AURA has distributed $0.00 in dividends over the past five years and lists no historical stock split data. The page also presents current stock per

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 06:10
Source
TradingKey
TradingKey Direct company coverage

Aura Biosciences Inc (AURA) Institutional Confidence

This article provides details on the institutional confidence score for Aura Biosciences Inc. (AURA), alongside a list of its major institutional shareholders and their shareholdings. The data includes the number of shares held by firms like Frazier Life Sciences Management, Adag

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 00:09
Source
TradingKey
Stock Titan Direct company coverage

Aura Biosciences (AURA) seeks charter increase to 500M shares; equity-plan tweak

Aura Biosciences is seeking shareholder approval to increase its authorized common shares from 150 million to 500 million and to amend its 2021 Stock Option and Incentive Plan. The proposed charter amendment aims to provide flexibility for future capital raising, acquisitions, an

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Tax-related Aura Biosciences (AURA) insider sale covers RSU withholding

Aura Biosciences officer Anthony S. Gibney automatically sold 12,824 shares of common stock at $6.42 per share on June 16, 2026. This sale was conducted to cover tax withholding obligations arising from vested restricted stock units, and it was not a discretionary transaction. Fo

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Aura Biosciences (AURA) files Form 144 to resell 37,500 RSU shares

Aura Biosciences (AURA) has filed a Form 144 to report a proposed resale of 37,500 shares of common stock. These shares are associated with a restricted stock unit (RSU) award granted under the company's 2021 Stock Option and Incentive Plan, dated June 2, 2025. The Form 144 itsel

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Aura Biosciences (AURA) awards director RSUs and $6.21 stock options

Aura Biosciences director Antony C. Mattessich was granted 15,000 Restricted Stock Units (RSUs) and stock options for 30,000 shares at an exercise price of $6.21 per share on June 11, 2026. These equity awards were granted under the company's 2021 Stock Option and Incentive Plan

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 20:10
Source
Stock Titan